CYPH
CYPHERPUNK TECHNOLOGIES INC.
Key Financials
Revenue
$1.5M
0.0%
Net Income
$4.8M
↑ 107.1%
EPS (Diluted)
$0.07
↑ 103.9%
Operating Income
$-41067000
↑ 41.4%
Total Assets
$163.2M
↑ 232.2%
Total Liabilities
$9.7M
↓ 31.3%
Shareholders' Equity
$153.5M
↑ 338.0%
Cash & Equivalents
$14.0M
↓ 70.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| S-8 | 6/9/2026 | View on SEC |
| 8-K | 5/26/2026 | View on SEC |
| 8-K | 5/14/2026 | View on SEC |
| 10-Q | 5/14/2026 | View on SEC |
| ARS | 4/29/2026 | View on SEC |
| DEFA14A | 4/29/2026 | View on SEC |
| DEF 14A | 4/29/2026 | View on SEC |
| 8-K | 4/10/2026 | View on SEC |
| 4 | 3/30/2026 | View on SEC |
| 144 | 3/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CYPH |
| Company Name | CYPHERPUNK TECHNOLOGIES INC. |
| CIK | 1509745 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617 252 4343 |